Moderna says its low-dose COVID vaccine generates immune response in kids October 25, 2021 Moderna says its clinical trials with children aged six to 11 showed two doses that were half the size of its adult shots produced similar levels of virus-fighting antibodies in children. Labels: CBC | Health News health Share to: Twitter Facebook URL Print Email
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.